medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 2

<< Back Next >>

Rev Mex Pediatr 2012; 79 (2)

Apnea in premature infants

Cullen BPJ
Full text How to cite this article

Language: Spanish
References: 25
Page: 86-91
PDF size: 70.31 Kb.


Key words:

Preterm apnea, bradicardia, methylxantines, kinesthesic stimulation.

ABSTRACT

The apnea of the preterm infant is one of the most common problems in the neonatal intensive care unit and has a complex physiopathology still not well understood. It has a multifactorial origin including genetic factors but there are problems that can clearly activate it. The treatment consists of non-pharmacologic measures and methylxantines that have proven wide effectiveness.


REFERENCES

  1. Dudell GG, Stoll B. Respiratory tract disorders. En: Kleigman RM, Behrman R, Jenson HB, Stanton B. Nelson Textbook of Pediatrics, 18th edition. Philadelphia: Saunders; 2007: 729-30.

  2. National Institutes of Health, Consensus Development Conference on Infantile Apnea and Home Monitoring, Sept 29 to Oct 1, 1986. Pediatrics 1987; 79: 292-9.

  3. Martin RJ, Abu-Shaweesh JM, Baird TM. Pathophysiologic mechanisms underlying apnea of prematurity. Neoreviews 2002; 3: e59.

  4. Blackmon LR, Batton DG, Bell EF, Engle WA, Kanto WP, Martin GI et al. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003; 111: 914-7.

  5. Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apnea in newborn babies. Aust Pediatr J 1981; 17: 273-6.

  6. Bakewell-Sachs S, Medoff-Cooper B, Escobar GJ, Silber JH, Lorch SA. Infant functional status: the timing of physiologic maturation of premature infants. Pediatrics 2009; 123(5). Available at: www.pediatrics.org/cgi/content/full/123/5/e878

  7. Bloch-Salisbury E, Hua HM, Sharma P, Boyd T, Bednarek F, Paydafar D. Heritability of apnea of prematurity: a retrospective twin study. Pediatrics 2010; 126: e779-87.

  8. Petronis A. Epigenetics and twins: three variations on the theme. Trends Genet 2006; 22: 347-50.

  9. Baird TM, Martin RJ, Jalal M, Abu-Shaweesh. Clinical associations, treatment, and outcome of apnea of prematurity. Neoreviews 2002; 3: 66.

  10. Di Fiore JM, Arko M, Ehitehouse M, Kimball A, Martin RJ. Apnea is not prolonged by acid gastroesophageal reflux in preterm infants. Pediatrics 2005; 118: 1059-63.

  11. Sale SM. Neonatal apnea. Best Pract Res Clin Anaesthesiol 2010; 24: 323-36.

  12. Lemke RP, Idiong N, Al-Saedi S, Kwiatkowski K, Cates DB, Rigatto H. Evidence of a critical period of airway instability during central apneas in preterm infants. Am J Respir Crit Care Med 1998; 157: 470-4.

  13. Poets CF. Apnea of prematurity: What can observational studies tell us about pathophysiology? Sleep Med 2010; 11: 701-7.

  14. Thompson MW, Hunt CE. Control of breathing: development, apnea of prematurity, apparent life-threatening events, sudden infant death syndrome. In: McDonald MG, Mullet MD, Seshia MK. Avery’s Neonatology Pathophysiology & Management of the Newborn, 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2005: 535-52.

  15. Osborn DA, Henderson-Smart DJ. Kinesthetic stimulation for preventing apnea in premature infants. Cochrane Database of Systematic Review 2002; (2): CD000373.

  16. Osborn DA, Henderson-Smart DJ. Kinesthetic stimulation for treating apnea in preterm infants. Cochrane Database of Systematic Reviews 1999; (1): CD000499.

  17. Osborn DA, Henderson-Smart DJ. Kinesthetic stimulation versus methylxanthine for apnea in preterm infants. Cochrane Database of Systematic Reviews 1998 (2): CD000502.

  18. Reyes-Torres R, Cordero-González G, Álvarez-Peña I. Apnea de la prematurez. Perinatol Reprod Hum 2008; 22: 279-89.

  19. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W. Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354: 2112-21.

  20. Davis PG, Schmidt B, Roberts RS, Doyle LW, Asztalos E, Haslam R, Sinha Sunil, Tin W. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr 2010; 156: 382-7.

  21. Dukhovny D, Lorch SA, Schmidt B, Doyle LW, Kok JH, Roberts RS, Kamholz KL, Wenyang NW, Zupancic JAF. Economic evaluation of caffeine for apnea of prematurity. Pediatrics 2011; 127: e146-55.

  22. Marlier L, Gaugler C, Messer J. Olfactory stimulation prevents apnea in premature newborns. Pediatrics 2005; 115: 83-8.

  23. Taylor HG, Schatschneider C, Hack M. Predictors of early school age outcomes in very low birth weight children. J Dev Bhav Pediatr 1999; 20: 205-6.

  24. Hoffman HJ, Damus K, Hillman L, Kongrad E, Risk factors for SIDS. Results of the National Institutes of Child Health and Human Development SIDS Cooperative Epidemiological Study. Ann NY Acad Sci 1988; 533: 13-30.

  25. Mayor NH, Hoffman HJ. Prematurity, sudden infant death syndrome and age of death. Pediatrics 1995; 96: 464-71.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2012;79